REFERENCES
- Manco-Johnson MJ. Controversies in neonatal thrombotic disorders. In: Ohls R, Yoder MC, eds. Hematology, Immunology and Infectious Disease: Neonatology Questions and Controversies. Vol. 1. Philadelphia: Saunders Elsevier; 2008:58–74.
- Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost. 1995;74:415–425.
- Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics. 1995;96:939–943.
- Demirel N, Aydın M, Zenciroğlu A, Neonatal thrombo-embolism: risk factors, clinical features and outcome. Ann Trop Paeditr. 2009;29:271–279.
- Cheah FC, Boo NY, Rohana J, Yong SC. Successful clot lysis using low dose of streptokinase in 22 neonates with aortic thromboses. J Paediatr Child Health. 2001;37(5):479–482.
- Nowak-Göttl U, Schwabe D, Schneider W, Thrombolysis with recombinant tissue-type plasminogen activator in renal venous thrombosis in infancy. Lancet. 1992;340:1105.
- Dillon PW, Fox PS, Berg CJ, Recombinant tissue plasminogen activator for neonatal and pediatric vascular thrombolytic therapy. J Pediatr Surg. 1993;28:1264–1269.
- Farnoux C, Camard O, Pinquier D, Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. J Pediatr. 1998;133(1):137–140.
- Aydin B, Dilli D, Uzunaliç N, Calcified thrombosis of the inferior vena cava extending to renal veins in a newborn with homozygous MTHFR a1298c mutation. Genet Couns. 2012;23(4):523–527.
- Guyatt GH, Akl EA, Crowther M, Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):7S–47S.
- Kothari SS, Varma S, Wasir HS. Thrombolytic therapy in infants and children. Am Heart J. 1994;127:651–657.
- Hartmann J, Hussein A, Trowitzsch E, Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature. Arch Dis Child Fetal Neonatal Ed. 2001;85(1):18–22.
- Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children. Fourth ACCP consensus conference on antithrombotic therapy. Chest. 1995;108(Suppl):506S–522S.
- Smets K, Vanhaesebrouck P, Voet D, Use of tissue type plasminogen activator in neonates: case reports and review of the literature. Am J Perinatol. 1996;13(4):217–222.
- Leaker M, Massicotte MP, Brooker LA. Thrombolytic therapy in pediatric patients: a comprehensive review of the literature. Thromb Haemost. 1996;76:132–134.
- Zenz W, Muntean W, Beitzke A, Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children. Br Heart J. 1993;70:382–385.